|
|
Post by kc on Jan 8, 2022 23:26:07 GMT -5
Detailed below are 3 sources in which Mannkind CEO Michael Castagna has made reference to the new Afrezza “Consignment Model”. #1 - From the November 9, 2021 Mannkind 3Q 2021 Earnings Call transcript from Seeking Alpha (with typo's): seekingalpha.com/article/4467643-mannkind-corporation-mnkd-ceo-michael-castagna-on-q3-2021-results-earnings-call-transcript“The third focus is launching a consignment model of top 3 pharmacy chain. And what this means is instead of having middleman involved in our inventory chain of command, we will now have inventory stockpiled with a third-party chain, which will improve patient access ultimately decreased costs along the value chain.”
#2 - From the same Earnings Call, the associated Slide #7 titled “Afrezza Q4 Focus”: static.seekingalpha.com/uploads/sa_presentations/472/76472/original.pdf“Creating consignment model with a top 3 pharmacy chain to improve patient access”
“Launching pilot to help improve patient retention during first 12 weeks of treatment “
#3 - From the December 13, 2021 Lytham Partners Winter 2021 Investor Conference Presentation by Michael Castagna (transcribed by sr-71 from the archived link available from Mannkind's website) - Beginning at 17:16 in the video: investors.mannkindcorp.com/events/event-details/lytham-partners-winter-2021-investor-conference“ … so on the consignment model, we moved a chunk of our business from the wholesalers to the consignment model with one of the retail chains; we're not saying who it is. It's a couple of weeks in and I have only heard of minor disruption so far, we will see when we get the data in. But that will be a Q4 event that we'll know once we wrap up the year, but so far it seems like it's going fine and it's critical to our permanent care pilot because one of the things we are doing is lowering the price of Afrezza to $35. So anyone on Medicare can't complain, they are going to have access to Afrezza for $35. That's huge. Medicare is about 40% of the insulin market and we think it is an opportunity to help a lot of patients. So let's see how it goes, but that's one thing the consignment model enables us to do at a lower cost, to bring the cost down to people living with diabetes … “
Several key conclusions can be drawn from these references: - This is a partnership with a Top 3 pharmacy chain.
- Afrezza inventory is to be stockpiled with this 3rd party chain, which will lower costs by reducing dependence upon pharmaceutical wholesalers.
- This model is closely linked to Mannkind's new Permanent Care Pilot program, which will lower the price of Afrezza to $35 for, in MC's exact words, “anyone on Medicare”. He also states “That's huge. Medicare is about 40% of the insulin market”.
- There are many unknowns. For instance, it's currently unclear how this much lower sales revenue per prescription will eventually become profitable. Perhaps the strategy is to go for hockey stick growth in market share, while looking for opportunities to become more efficient while perhaps attempting to raise prices later?
- The consignment model does not appear to have any association with Medicare's “Part D Senior Savings Model”, which, as nylefty has graciously pointed out many times, requires voluntary participation by Part D Medicare Plan Providers, and we are unaware of any who have opted in for Afrezza. However, it's interesting is that the $35 insulin price point to Medicare patients is common to both programs.
I look forward to hearing other MNKD ProBoards members' thoughts on the consignment model. Very interesting concept if can be pulled off. Would like to see it with somebody like Walmart / Sams and a secondary partnership with CVS |
|
|
|
Post by kc on Sept 30, 2021 15:33:07 GMT -5
[/quote]I am guessing the price action signals there is going to be another run on toilet paper. Load up. Sell it to your friends in their time of need. [/quote]
You’re Sh-ting me.
|
|
|
|
Post by kc on Sept 30, 2021 14:02:15 GMT -5
I have this friend who is in the drug packaging business. He sold his building in order to invest inmore equipment inside the facility. He said he would get a much better return on building out new equipment/packaging lines that he would on his real estate.
I have no trouble with mannkind doing this has the cost of building out new manufacturing lines for multiple products would be very expensive.
|
|
|
|
Post by kc on Jun 10, 2021 7:02:34 GMT -5
It sounds like MannKind is investing in this other company. That’s a interesting move for the company. Again there are things happening behind the scene that none of us know. I just wonder how that is tied into United therapeutics.
|
|
|
|
Post by kc on Apr 15, 2021 16:32:34 GMT -5
MNKD has more than $300M CASH - enough to get to break even.
I heard that they hedged their finances by buying $25 million worth of bitcoin when it was at $45,000 a share.
All will be 👌
|
|
|
|
Post by kc on Apr 15, 2021 16:19:08 GMT -5
After all these years does one good quarterly make it all go away? Not a chance in hell! This has only just begun. I am ready for the ride of a lifetime and its going to take a whole lot of quarters to make me go away. So keep counting. Its Happening! It will never be the ride of a lifetime but it will be a good ride one that will get everybody who’s been around since 2014 whole |
|
|
|
Post by kc on Apr 7, 2021 19:05:49 GMT -5
Get me $20.00 and it will help me get the memory of the shares I sold for a loss in 2016 to offset a big capital gain I had that year. But wait.... After the wash sale date had passed, I foolishly bought back into this cult stock. Fortunately the buy back in shares are all green these days. But, I was never smart enough to buy any under $1.00. My bad for not taking advantage. My only regret is that I bought MannKind stock in 2014 and sold some Home Depot stock to do it. I should have kept that stock. My other regret is not buying Amazon shares or Apple shares in 2014. But then again I would not be a member of this cult today had I been that smart. Next time I will us my KOP...... AL MANN had a great KOP. I bought Apple in 2003-4. That was when I also bought Nokia and Lucent and other stocks that I sold at a loss or a very minimal profit. I still own perhaps half of the APPL I bought, but over the years the sale of portions has purchased three cars outright and other necessities, when cash was simply unavailable. I'm not a gambler by any means. I lost a lot of money over the years (a lot for someone like me who is not by any stretch wealthy, but rather independent), but the few that won, more than made up for it. What I learned is, look for real value, cut the duds, hold the winners, periodically reassess the value and wait. I was never smart enough to to try and time a sale of MannKind stock. Would have, Could have, Should have sold when it hit some milestones and then bought back in. But I was always afraid to miss out on the ultimate deal when it happens. Owning MannKind has taught me some lessons about having patience and being humble. I have a large portfolio with more than 35 positions. Many of them for 30 + years. So I’m not a rookie investor. I got sucked into MannKind because of the potential of the company. So Perhaps it was greed as I thought as many on this board thought that Afrezza was going to be something really special for the diabetic. I still believe but now know that the winner will be multiple uses of Technosphere. In closing I have never followed or paid attention to another position like I have with MannKind. I know that my patience one day will be achieved when the company hits a very successful milestone with multiple products using their Technosphere platform. That Afrezza goes big when they get pediatric approval. Until that day I will continue to believe that Mike C. And his team including the Board of Directors are working hard on out behalf as shareholders. I don’t begrudge their salaries, Stock bonus awards. They are invested in seeing this company in the right direction to being a winner. |
|
|
|
Post by kc on Apr 6, 2021 21:25:10 GMT -5
This position should be posted on ST so that some hard working engineer sees that something big is going to happen at MannKind.
Support the technology transfer process for new product introduction into Manufacturing.
|
|
|
|
Post by kc on Apr 6, 2021 21:16:16 GMT -5
Get me $20.00 and it will help me get the memory of the shares I sold for a loss in 2016 to offset a big capital gain I had that year.
But wait.... After the wash sale date had passed, I foolishly bought back into this cult stock.
Fortunately the buy back in shares are all green these days.
But, I was never smart enough to buy any under $1.00.
My bad for not taking advantage.
My only regret is that I bought MannKind stock in 2014 and sold some Home Depot stock to do it. I should have kept that stock.
My other regret is not buying Amazon shares or Apple shares in 2014. But then again I would not be a member of this cult today had I been that smart.
Next time I will us my KOP...... AL MANN had a great KOP.
|
|
|
|
Post by kc on Apr 6, 2021 21:10:17 GMT -5
Like I keep saying we will have the run up between April and November. First is the submission and then is the approval ..go back and look at the long term chart and observe the run ups to FDA approval. JMHO Sports, I am very please that you are optimistic. I know for sure that you are not a pumper. I also know that you know the whole history of MNKD (and Afrezza) better than most. Sports is not a pumper? Wow! For almost 6 or 7 years I had it all wrong......  |
|
|
|
Post by kc on Apr 1, 2021 14:09:32 GMT -5
From the press release: "PH is estimated to affect at least 15% of patients with early-stage ILD (approximately 30,000 PH-ILD patients in the United States) and may affect up to 86% of patients with more severe ILD." So, UTHR is telling you that, right now, they can address 30,000 patients for the indication "PH-ILD". There are a lot of patients with "ILD" who have not been categorized with "PH". The "PH" designation requires a right heart cath, and in the past pulmonologists have often not ordered this procedure because there was no treatment anyway. Now suddenly there is a treatment and gradually there will be more right heart caths and the addressable market "PH-ILD" will grow. A doctor friend was just telling me that unfortunately a lot of Covid patients now have Pulmonary issues. |
|
|
|
Post by kc on Mar 10, 2021 7:47:20 GMT -5
So it is Amgen that's buying Mannkind. They must be behind this latest money raise. I assume that you're joking. Even Kuka seems to have given up on that fantasy.  Tell Kuka it’s Apple. Because they want to revolutionize diabetes treatment. There’s an app for that tied back to Bluehale. They want to beat Amazon and Jeff Bezos to the whole enchilada. “Apple now has $195.57 billion in cash on hand, up $3.7 billion. Apple now has $195.57 billion in cash on hand, up 2% from last quarter. Apple regularly hosts one of the largest cash piles in the U.S. However, it's a 5.5% drop from the $207.06 billion in cash Apple had during the same quarter a year ago.” |
|
|
|
Post by kc on Mar 9, 2021 23:20:34 GMT -5
Just read the transcripts from the conference call today. In my opinion Mike hit a grand slam. On seeking Alpha I posted the following comment.
Very good presentation by Mike. The future in my opinion looks to be very bullish. There’s a Lotta good things in the pipeline that will happen during the next 24 to 48 months.
The cloud that has hung over this company for many years should now be all blue sky. I believe that MannKind has a clear plan and long term shareholders like myself will eventually see PPS above $10 per share.
MannKind Corporation (MNKD) CEO Michael Castagna Presents at H.C. Wainwright Global Life Sciences Conference (Transcript)
|
|
|
|
Post by kc on Feb 27, 2021 11:30:16 GMT -5
Longliner, in your slightly salacious metaphor, couldn’t you see the poison pill being an STD for our prom girl? Based on this thread, I’m upping my buyout price with which I’d be happy to $15! Get me $15.00 before the Biden Administrative changes the capital gains tax. There might be a lot of mergers and buyouts if the House, Senate and ultimately the President change capital gains taxes. That could happened in 2021 or 2022. |
|
|
|
Post by kc on Feb 27, 2021 11:26:04 GMT -5
I used to say get me to $10.00 or $15.00 and that would be fair market value. I am not in favor of sell the Real Estate. It might get cash back but we don’t have the value it brings. Of course we have the equipment in the plant and would gain a long term lease. But I alway wanted my business to own its Real Estate.
Get me a buy out offer of $25.00 and I would tender my shares. A buy out might not mean cash it might be shares in the company buying Mannkind. You might not like that buyer or want its shares.
|
|
